Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease (Q37088891)

18 August 2017

1 reference

title

Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease (English)

1 reference

stem cell transplantation

18 August 2017

main subject

1 reference

2

Steven Z Pavletic

1 reference

18 August 2017

Nikolay P Nikolov

1

1 reference

18 August 2017

publication date

19 February 2008

1 reference

Nature Clinical Practice Rheumatology

18 August 2017

published in

1 reference

18 August 2017

volume

4

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

184-191

1 reference

Hematopoietic stem-cell transplantation

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Hematopoietic-cell transplantation at 50.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Treatment of severe autoimmune disease by stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Immune ablation and stem-cell therapy in autoimmune disease. Experimental basis for autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Stem cell transplantation in experimental models of autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

From T to B and back again: positive feedback in systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Renewing the T cell repertoire to arrest autoimmune aggression

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

T(H)-17 differentiation: of mice and men

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Hematopoietic cell transplantation for benign hematological disorders and solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autoimmunity following haematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous hematopoietic stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous stem cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Hematopoietic stem cell transplantation for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a r

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Cell therapy for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0756

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0756

1 reference

18 August 2017

1 reference